Mirati Therapeutics Inc. buy B. Riley
Start price
09.08.23
/
50%
€33.71
Target price
09.08.24
-
Performance (%)
60.19%
End price
10.08.24
-
Summary
This prediction is currently being closed. The BUY prediction by B__Riley for Mirati Therapeutics Inc. has seen massive gains of 60.19%. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by B__Riley for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Mirati Therapeutics, Inc. (NASDAQ: MRTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating.
Ratings data for MRTX provided by MarketBeat
In the thread Trading Mirati Therapeutics Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten

